Jeffrey Bluestone
At a glance: Jeffrey Bluestone is Director at Gilead Sciences (GILD). Their latest SEC Form 4, filed Aug 21, 2026, reported a sale of $167K. On file: 0 purchase lines ($0) and 7 sale lines ($2.0M).
Disclosed holdings: about $1.7M of GILD stock: 10,066 shares reported on their latest Form 4 (filed Aug 21, 2026), valued at the Nov 19, 2026 close of $167.13. This counts only GILD shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Gilead Sciences, Inc. (GILD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Jeffrey Bluestone's InsiderPrint
7 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 7 times a year, typically $242K a trade; most sales are on a pre-planned 10b5-1 schedule; trades in the same month most years.
- Bump outward: a purchase (0)
- Dent inward: a sale (7)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Michael Patsalos-FoxDirector · CTSH · 99% match
- Victor K. LeeDirector · MPWR · 99% match
- Mani SundaramEvp And Gm Security · AKAM · 99% match
- Joshua ScuttPresident · PCTY · 99% match
- Peter J. BulgarelliCEO · VTR · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 21SEC | GILDGilead Sciences, Inc. | Sell Plan | 1,16510,066 held (−10%) | $143.75 | $167K | +16.3% |
| Aug 21SEC | GILDGilead Sciences, Inc. | Sell Plan | 1,81610,066 held (−15%) | $144.92 | $263K | +15.3% |
| Aug 21SEC | GILDGilead Sciences, Inc. | Sell Plan | 1,65810,066 held (−14%) | $145.73 | $242K | +14.7% |
| Aug 21SEC | GILDGilead Sciences, Inc. | Sell Plan | 2610,066 held (−0%) | $146.36 | $4K | +14.2% |
| Aug 21SEC | GILDGilead Sciences, Inc. | Sell Plan | 33510,066 held (−3%) | $146.26 | $49K | +14.3% |
| Jan 21SEC | GILDGilead Sciences, Inc. | Sell Plan | 5,0008,920 held (−36%) | $123.50 | $618K | +35.3% |
| Dec 1SEC | GILDGilead Sciences, Inc. | Sell | 5,0008,920 held (−36%) | $125.08 | $625K | +33.6% |
- Sell
Director Jeffrey Bluestone sold $167K of GILD at $143.75 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jeffrey Bluestone sold $263K of GILD at $144.92 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jeffrey Bluestone sold $242K of GILD at $145.73 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jeffrey Bluestone sold $4K of GILD at $146.36 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jeffrey Bluestone sold $49K of GILD at $146.26 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jeffrey Bluestone sold $618K of GILD at $123.50 — cuts the stake by 36%; pre-scheduled 10b5-1 plan sale.
Follow Jeffrey Bluestone
Get one email when Jeffrey Bluestone files a new purchase or sale. Free.
At most one email a day about Jeffrey Bluestone, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.